Zymo Research Corp.: Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
Zymo Research Corporation acknowledges the recent ruling, on March 14, 2025, by the United States District Court for the Central District of California ...
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
Zymo Research Corporation acknowledges the recent ruling, on March 14, 2025, by the United States District Court for the ...
FMIBlog6d
Global Electrophoresis Market Poised for Strong Growth, Expected to Reach USD 3,523.50 Million by 2033 at a CAGR of 4.5% | FMI
The global electrophoresis market is set to witness substantial growth, with its valuation projected to rise from USD 2,268.8 million in 2023 to USD 3,523.50 million by 2033. This expansion reflects a ...
eLife7d
Genome organization by SATB1 binding to base-unpairing regions (BURs) provides a scaffold for SATB1-regulated gene expression
Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...
Manchester looks to build on life sciences cluster effect
Nevertheless, Manchester’s life sciences cluster has bounced back and evolved following AstraZeneca’s departure, Sheppard ...
Arabian Post10d
Catalonia’s Biotech Sector Flourishes as Barcelona Emerges as a Leading Life Sciences Hub
Dubai Catalonia has solidified its position as a prominent biotechnology hub, with Barcelona at its epicenter, fostering ...
QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel
QIAGEN N.V. QGEN has secured FDA clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, bolstering its syndromic testing portfolio in the United States. This marks the ...
EuropaWire12d
QIAGEN Gains FDA Approval for New QIAstat-Dx Gastrointestinal Panel 2 Mini B, Expanding Syndromic Testing Options
QIAGEN has received FDA approval for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding its syndromic testing offerings for gastrointestin ...
Credence Research Inc.: Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50% CAGR - Credence Research
The Global Microplates Market is experiencing steady growth, driven by the increasing adoption of high-throughput screening (HTS) in drug discovery ...
DutchNews.NL14d
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
Automation solutions bring these processes together into seamless and cost-effective workflows. QIAGEN serves over 500,000 ...
Universiteit Utrecht14d
Department of Earth Sciences
The Earth Sciences contribute to answers on a wide range of societal and economic questions in areas such as: the natural means of existence (water, raw materials, the energy transition), the ...